Literature DB >> 17373715

Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.

Tyark Eilers1, Stefan Machtens, Hossein Tezval, Christoph Blaue, Ralf Lichtinghagen, Jörn Hagemann, Udo Jonas, Jürgen Serth.   

Abstract

BACKGROUND: The prospective diagnostic efficiency of quantitative glutathione S transferase (GSTP1) promoter hypermethylation analysis in biopsy washing samples has not been determined so far.
METHODS: Biopsies were obtained prospectively from 86 patients suspicious for prostate cancer (CaP). After isolation of DNA from biopsy washings and bisulfite conversion methylated and unmethylated GSTP1 sequences were specifically quantitated by real-time fluorescence PCR. Relative degrees of methylation were compared to results of histopathological examination.
RESULTS: Increased relative methylation was found for the CaP group (mean 28.1%) compared to biopsies without histological evidence for malignancy (5.2%; P < 0.001). A sensitivity and specificity of 92% and 86% and positive and negative predictive values of 82% and 94% were obtained. Receiver operating characteristic (ROC) analysis demonstrated a value of 0.90 (95% CI 0.82-0.98) for the area under curve (AUC).
CONCLUSIONS: Biopsy washing DNA GSTP1 hypermethylation analysis demonstrates a high diagnostic efficacy which is comparable to the retrospective analysis of biopsy tissue specimens. Moreover it is compatible with routine biopsy examination thus permitting further prospective evaluation in CaP diagnosis. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373715     DOI: 10.1002/pros.20546

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  3 in total

1.  [Detection of hypermethylated gene promotors in diagnosis of prostate cancer].

Authors:  T Eilers; S Machtens; H Tezval; C Blaue; R Lichtinghagen; J Hagemann; U Jonas; J Serth
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

2.  shRNA-mediated GSTP1 gene silencing enhances androgen-independent cell line DU145 chemosensitivity.

Authors:  Peng Jin; Jinliang Xie; Xiangrong Zhu; Cheng Zhou; Xiang Ding; Luoyan Yang
Journal:  Int Urol Nephrol       Date:  2013-12-11       Impact factor: 2.370

3.  Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.

Authors:  Maibritt Nørgaard; Christa Haldrup; Tine Maj Storebjerg; Else Marie Vestergaard; Peter J Wild; Søren Høyer; Michael Borre; Torben Falck Ørntoft; Karina Dalsgaard Sørensen
Journal:  Int J Mol Sci       Date:  2017-09-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.